Fungal infections are on the rise, driven by a growing population at risk and climate change.
Currently available antifungals include only five classes, and their utility and efficacy in …

In the past decade RNA-based therapies such as small interfering RNA (siRNA) and
messenger RNA (mRNA) have emerged as new and ground-breaking therapeutic agents for …

Introduction Aerosol therapy is commonly prescribed in the mechanically ventilated patient.
Jet nebulizers (JN) and vibrating mesh nebulizers (VMN) are the most common nebulizer …

Drug delivery devices used for aerosol therapy during mechanical ventilation to ease the
symptoms of respiratory diseases provide beneficial treatment but can also pose challenges …

Nebulisers are devices that reduce a body of liquid into a fine aerosol suitable for inhalation.
Utilising the efficiency of pulmonary drug absorption, they offer a safe and powerful modality …

Respiratory disease is the leading cause of death in children under the age of 5 years old.
Currently available treatments for paediatric respiratory diseases including …

Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF). CF patients
inhale antibiotics regularly as treatment against persistent bacterial infections. The goal of …

Introduction Aerosol therapy is often prescribed concurrently during invasive mechanical
ventilation (IMV). This study determines the effects of nebuliser position, circuit …

Question addressed by study Administration of aerosol to patients receiving high-flow nasal
oxygen (HFNO) ranges from concurrent aerosol delivery by mouthpiece to aerosol via …

The emergence of specific drug–device combination products in the inhalable
pharmaceutical industry demands more sophistication of device functionality in the form of …